Jim Rechtin will assume the role of president and CEO of Humana on July 1, the company said May 13.
Mr. Rechtin joined Humana as chief operating officer in January after serving as CEO of Nashville, Tenn.-based Envision Healthcare since 2020. Before joining Envision Healthcare, Mr. Rechtin spent six months as president of UnitedHealth Group subsidiary OptumCare. He was previously senior vice president of strategy and California market president at DaVita Medical Group.
Humana’s current CEO, Bruce Broussard, will resign from Humana's board of directors on July 1 and will serve as a strategic advisor to the company into 2026. Mr. Rechtin will join the board effective July 1. The transition plan was first announced in October but final dates were unclear.
Mr. Rechtin will be paid a base salary of $1.1 million as COO, which will increase to $1.25 million once he assumes the CEO role, according to documents Humana filed with the Securities and Exchange Commission. He will be eligible for executive incentive compensation targeted at 200 percent of his base salary earnings as CEO and receive an initial stock grant of $6 million as well as long-term incentive compensation, also equaling $6 million.
"I am incredibly excited to be named CEO of Humana and humbled to have the opportunity to lead 65,000 dedicated teammates as we seek to provide better health outcomes at lower costs for our members and customers,” Mr. Rechtin said. "I appreciate the trust and confidence shown to me by the Humana Board, Bruce and the entire leadership team. As an enterprise, we have tremendous growth prospects, driven by a differentiated value proposition and attractive market fundamentals. I am committed to innovating and improving our operations even further, finding better ways of working and providing equitable access to high quality healthcare while generating long-term shareholder value."